,
Quel est le moment optimal pour administrer les IPP? Pharmactuel, Disponible sur, vol.36, p.10, 2003. ,
, Prise en charge du reflux gastro-oesophagien sans oesophagite chez l'adulte, 2011.
Connaître les cyclooxygénases pour mieux contrôler les effets des antiinflammatoires non-stéroïdiens. médecine/sciences, vol.10, p.468, 1994. ,
, Prévention des lésions gastro-duodénales induites par les antiinflammatoires non stéroïdiens (AINS), 2009.
Syndrome de Zollinger Ellison ,
Les inhibiteurs de la pompe à protons chez l'adulte, 2009. ,
Proton Pump Inhibitors and Histamine-2 Receptor Antagonists are Associated with Hip Fractures among At-Risk Patients, Gastroenterology. juill, vol.139, issue.1, pp.93-101, 2010. ,
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA. 27 déc, vol.296, issue.24, pp.2947-53, 2006. ,
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebocontrolled trial, Am J Gastroenterol. juill, vol.105, issue.7, pp.1531-1538, 2010. ,
Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy, Gastroenterology. juill, vol.137, issue.1, p.1, 2009. ,
Uses of proton pump inhibitors and hypomagnesemia, Pharmacoepidemiol Drug Saf. mai, vol.21, issue.5, pp.553-562, 2012. ,
A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults, J Clin Epidemiol. 1 avr, vol.57, issue.4, pp.422-430, 2004. ,
Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults, Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 1 sept, vol.73, issue.17, pp.126-132, 2016. ,
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection, Arch Intern Med. 10 mai, vol.170, issue.9, pp.772-780, 2010. ,
Systematic review of the risk of enteric infection in patients taking acid suppression, Am J Gastroenterol. sept, vol.102, issue.9, pp.2047-56, 2007. ,
Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis, Expert Rev Clin Pharmacol. mai, vol.5, issue.3, pp.337-381, 2012. ,
Proton Pump Inhibitors and Acute Interstitial Nephritis, Clin Gastroenterol Hepatol. 1 mai, vol.4, issue.5, pp.597-604, 2006. ,
Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases, Nephrology, vol.11, issue.5, pp.381-386, 2006. ,
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study, BMJ. 30 mai, vol.365, p.1580, 2019. ,
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis, JAMA Neurol. avr, vol.73, issue.4, pp.410-416, 2016. ,
No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis, J Gastroenterol Hepatol. 23 juill, 2019. ,
,
,
Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé, 2018. ,
Comprehensive geriatric assessment: a meta-analysis of controlled trials, Lancet Lond Engl, vol.342, issue.8878, pp.1032-1038, 1993. ,
Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board, Geriatr Gerontol Int, vol.13, issue.4, pp.1002-1011, 2013. ,
,
, Therapie. déc, vol.71, issue.6, pp.589-93, 2016.
Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?, Eur J Clin Pharmacol. 1 sept, vol.75, issue.9, pp.1327-1336, 2019. ,
Inappropriate prescribing of proton pump inhibitors in hospitalized patients, J Hosp Med. juin, vol.7, issue.5, pp.421-426, 2012. ,
Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice, J Manag Care Pharm JMCP. mai, vol.19, issue.4, pp.325-358, 2013. ,
Inappropriate prescribing of proton pump inhibitors in primary care, Postgrad Med J. janv, vol.83, issue.975, pp.66-74, 2007. ,
Inappropriate Prescription of Proton Pump Inhibitors in a Community Setting, Can J Hosp Pharm. août, vol.71, issue.4, pp.267-71, 2018. ,
Utilisation des inhibiteurs de la pompe à protons (IPP): étude observationnelle à partir des données du SNDS, 2015. ,
Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults, JAMA, vol.320, issue.18, pp.1889-98, 2018. ,
Ai-je encore besoin de ce médicament ?, 2014. ,
, Réseau canadien pour la déprescription. Ai-je encore besoin de ce médicament?, 2014.
, Annexe 1 : Exemple de bilan de médicamenteux réalisé par l'EMG
, Annexe 3 : Recommandations de prise en charge du reflux gastro-oesophagien sans oesophagite chez l'adulte par l'Assurance maladie
, Annexe 5 : Fiche Omédit « Votre médecin vous a prescrit un médicament inhibiteur de la pompe à protons (IPP)
, Arrêter mon médicament inhibiteur de la pompe à protons (IPP), c'est possible ! Annexe 7 : Fiche Omédit « Inhibiteur de la pompe à protons (IPP) : s'assurer de la pertinence des prescriptions